The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance

Journal of Immunology

Volumn 191, Issue 8, 2013, Pages 4367-4374

  Phieler, Julia ^a,b   Chung, Kyoung Jin ^a   Chatzigeorgiou, Antonios ^a,b   Klotzsche Von Ameln, Anne ^a,b   Garcia Martin, Ruben ^a   Sprott, David ^a   Moisidou, Maria ^c   Tzanavari, Theodora ^c   Ludwig, Barbara ^a   Baraban, Elena ^a   Ehrhart Bornstein, Monika ^a   Bornstein, Stefan R ^a   Mziaut, Hassan ^b   Solimena, Michele ^b   Karalis, Katia P ^a,c   Economopoulou, Matina ^a   Lambris, John D ^d   Chavakis, Triantafyllos ^a,b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POLARITY; COMPLEMENT ANAPHYLATOXIN C5A RECEPTOR GENE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; COMPLEMENT C5A; DIETARY FATS; FEMALE; FIBROSIS; INFLAMMATION; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; INTERLEUKIN-10; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; RECEPTOR, ANAPHYLATOXIN C5A; UP-REGULATION;

EID: 84885436588     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300038     Document Type: Article

References (60)

1. Schenk, S., M. Saberi, and J. M. Olefsky. 2008. Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 118: 2992-3002.
2. Odegaard, J. I., and A. Chawla. 2008. Mechanisms of macrophage activation in obesity-induced insulin resistance. Nat. Clin. Pract. Endocrinol. Metab. 4: 619-626.
3. Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante, Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112: 1796-1808.
4. Weber, C., and H. Noels. 2011. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17: 1410-1422.
5. Chatzigeorgiou, A., K. P. Karalis, S. R. Bornstein, and T. Chavakis. 2012. Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia 55: 2583-2592.
6. Chmelar, J., K. J. Chung, and T. Chavakis. 2013. The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance. Thromb. Haemost. 109: 399-406.
7. Ferrante, A. W., Jr. 2007. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J. Intern. Med. 262: 408-414.
8. Chawla, A., K. D. Nguyen, and Y. P. Goh. 2011. Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 11: 738-749.
9. Lumeng, C. N., S. M. Deyoung, J. L. Bodzin, and A. R. Saltiel. 2007. Increased inflammatory properties of adipose tissue macrophages recruited during dietinduced obesity. Diabetes 56: 16-23.
10. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686.
11. Morris, D. L., K. Singer, and C. N. Lumeng. 2011. Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states. Curr. Opin. Clin. Nutr. Metab. Care 14: 341-346.
12. Lumeng, C. N., J. B. DelProposto, D. J. Westcott, and A. R. Saltiel. 2008. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 57: 3239-3246.
13. Xu, H., G. T. Barnes, Q. Yang, G. Tan, D. Yang, C. J. Chou, J. Sole, A. Nichols, J. S. Ross, L. A. Tartaglia, and H. Chen. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112: 1821-1830.
14. Lumeng, C. N., S. M. Deyoung, and A. R. Saltiel. 2007. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am. J. Physiol. Endocrinol. Metab. 292: E166-E174.
15. Ricklin, D., G. Hajishengallis, K. Yang, and J. D. Lambris. 2010. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11: 785-797.
16. Hamad, O. A., J. Bäck, P. H. Nilsson, B. Nilsson, and K. N. Ekdahl. 2012. Platelets, complement, and contact activation: partners in inflammation and thrombosis. Adv. Exp. Med. Biol. 946: 185-205.
17. Pattrick, M., J. Luckett, L. Yue, and C. Stover. 2009. Dual role of complement in adipose tissue. Mol. Immunol. 46: 755-760.
18. Choy, L. N., B. S. Rosen, and B. M. Spiegelman. 1992. Adipsin and an endogenous pathway of complement from adipose cells. J. Biol. Chem. 267: 12736-12741.
19. Maslowska, M., H. Vu, S. Phelis, A. D. Sniderman, B. M. Rhode, D. Blank, and K. Cianflone. 1999. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur. J. Clin. Invest. 29: 679-686.
20. MacLaren, R., W. Cui, and K. Cianflone. 2008. Adipokines and the immune system: an adipocentric view. Adv. Exp. Med. Biol. 632: 1-21.
21. Mamane, Y., C. Chung Chan, G. Lavallee, N. Morin, L. J. Xu, J. Huang, R. Gordon, W. Thomas, J. Lamb, E. E. Schadt, et al. 2009. The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation. Diabetes 58: 2006-2017.
22. Höpken, U. E., B. Lu, N. P. Gerard, and C. Gerard. 1996. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383: 86-89.
23. Langer, H. F., K. J. Chung, V. V. Orlova, E. Y. Choi, S. Kaul, M. J. Kruhlak, M. Alatsatianos, R. A. DeAngelis, P. A. Roche, P. Magotti, et al. 2010. Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood 116: 4395-4403.
24. Kim, D. H., M. A. Sartor, J. R. Bain, D. Sandoval, R. D. Stevens, M. Medvedovic, C. B. Newgard, S. C. Woods, and R. J. Seeley. 2012. Rapid and weightindependent improvement of glucose tolerance induced by a peptide designed to elicit apoptosis in adipose tissue endothelium. Diabetes 61: 2299-2310.
25. Stanford, K. I., R. J. Middelbeek, K. L. Townsend, D. An, E. B. Nygaard, K. M. Hitchcox, K. R. Markan, K. Nakano, M. F. Hirshman, Y. H. Tseng, and L. J. Goodyear. 2013. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J. Clin. Invest. 123: 215-223.
26. Jonker, J. W., J. M. Suh, A. R. Atkins, M. Ahmadian, P. Li, J. Whyte, M. He, H. Juguilon, Y. Q. Yin, C. T. Phillips, et al. 2012. A PPARg-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nature 485: 391-394.
27. Kiechl, S., J. Wittmann, A. Giaccari, M. Knoflach, P. Willeit, A. Bozec, A. R. Moschen, G. Muscogiuri, G. P. Sorice, T. Kireva, et al. 2013. Blockade of receptor activator of nuclear factor-kB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat. Med. 19: 358-363.
28. Kornfeld, J. W., C. Baitzel, A. C. Könner, H. T. Nicholls, M. C. Vogt, K. Herrmanns, L. Scheja, C. Haumaitre, A. M. Wolf, U. Knippschild, et al. 2013. Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature 494: 111-115.
29. Choi, E. Y., V. V. Orlova, S. C. Fagerholm, S. M. Nurmi, L. Zhang, C. M. Ballantyne, C. G. Gahmberg, and T. Chavakis. 2008. Regulation of LFA-1-dependent inflammatory cell recruitment by Cbl-b and 14-3-3 proteins. Blood 111: 3607-3614.
30. Agouni, A., C. Owen, A. Czopek, N. Mody, and M. Delibegovic. 2010. In vivo differential effects of fasting, re-feeding, insulin and insulin stimulation time course on insulin signaling pathway components in peripheral tissues. Biochem. Biophys. Res. Commun. 401: 104-111.
31. Bajzer, M., M. Olivieri, M. K. Haas, P. T. Pfluger, I. J. Magrisso, M. T. Foster, M. H. Tschöp, K. A. Krawczewski-Carhuatanta, D. Cota, and S. Obici. 2011. Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice. Diabetologia 54: 3121-3131.
32. Eskan, M. A., R. Jotwani, T. Abe, J. Chmelar, J. H. Lim, S. Liang, P. A. Ciero, J. L. Krauss, F. Li, M. Rauner, et al. 2012. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat. Immunol. 13: 465-473.
33. Langer, H. F., E. Y. Choi, H. Zhou, R. Schleicher, K. J. Chung, Z. Tang, K. Göbel, K. Bdeir, A. Chatzigeorgiou, C. Wong, et al. 2012. Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ. Res. 110: 1202-1210.
34. Jiang, H., H. Zhu, X. Chen, Y. Peng, J. Wang, F. Liu, S. Shi, B. Fu, Y. Lu, Q. Hong, et al. 2007. TIMP-1 transgenic mice recover from diabetes induced by multiple low-dose streptozotocin. Diabetes 56: 49-56.
35. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
36. Kanda, H., S. Tateya, Y. Tamori, K. Kotani, K. Hiasa, R. Kitazawa, S. Kitazawa, H. Miyachi, S. Maeda, K. Egashira, and M. Kasuga. 2006. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116: 1494-1505.
37. Shaul, M. E., G. Bennett, K. J. Strissel, A. S. Greenberg, and M. S. Obin. 2010. Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet-induced obesity in mice. Diabetes 59: 1171-1181.
38. Khan, T., E. S. Muise, P. Iyengar, Z. V. Wang, M. Chandalia, N. Abate, B. B. Zhang, P. Bonaldo, S. Chua, and P. E. Scherer. 2009. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol. Cell. Biol. 29: 1575-1591.
39. Wentworth, J. M., G. Naselli, W. A. Brown, L. Doyle, B. Phipson, G. K. Smyth, M. Wabitsch, P. E. O'Brien, and L. C. Harrison. 2010. Pro-inflammatory CD11c+ CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 59: 1648-1656.
40. Cancello, R., J. Tordjman, C. Poitou, G. Guilhem, J. L. Bouillot, D. Hugol, C. Coussieu, A. Basdevant, A. Bar Hen, P. Bedossa, et al. 2006. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55: 1554-1561.
41. Lumeng, C. N., J. L. Bodzin, and A. R. Saltiel. 2007. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117: 175-184.
42. Yu, J., L. Shi, H. Wang, P. J. Bilan, Z. Yao, M. C. Samaan, Q. He, A. Klip, and W. Niu. 2011. Conditioned medium from hypoxia-treated adipocytes renders muscle cells insulin resistant. Eur. J. Cell Biol. 90: 1000-1015.
43. Gao, M., C. Zhang, Y. Ma, L. Bu, L. Yan, and D. Liu. 2013. Hydrodynamic delivery of mIL10 gene protects mice from high-fat diet-induced obesity and glucose intolerance. Mol. Ther. 10.1038/mt.2013.125.
44. Cui, W., S. Paglialunga, D. Kalant, H. Lu, C. Roy, M. Laplante, Y. Deshaies, and K. Cianflone. 2007. Acylation-stimulating protein/C5L2- neutralizing antibodies alter triglyceride metabolism in vitro and in vivo. Am. J. Physiol. Endocrinol. Metab. 293: E1482-E1491.
45. Kalant, D., S. A. Cain, M. Maslowska, A. D. Sniderman, K. Cianflone, and P. N. Monk. 2003. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. J. Biol. Chem. 278: 11123-11129.
46. Cui, W., M. Simaan, S. Laporte, R. Lodge, and K. Cianflone. 2009. C5a-And ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323IC5L2 mutation. Mol. Immunol. 46: 3086-3098.
47. Fisette, A., M. N. Munkonda, K. Oikonomopoulou, S. Paglialunga, J. D. Lambris, and K. Cianflone. 2013. C5L2 receptor disruption enhances the development of diet-induced insulin resistance in mice. Immunobiology 218: 127-133.
48. Phieler, J., R. Garcia-Martin, J. D. Lambris, and T. Chavakis. 2013. The role of the complement system in metabolic organs and metabolic diseases. Semin. Immunol. 25: 47-53.
49. Paglialunga, S., P. Schrauwen, C. Roy, E. Moonen-Kornips, H. Lu, M. K. Hesselink, Y. Deshaies, D. Richard, and K. Cianflone. 2007. Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. J. Endocrinol. 194: 293-304.
50. Cinti, S., G. Mitchell, G. Barbatelli, I. Murano, E. Ceresi, E. Faloia, S. Wang, M. Fortier, A. S. Greenberg, and M. S. Obin. 2005. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46: 2347-2355.
51. Addis-Lieser, E., J. Köhl, and M. G. Chiaramonte. 2005. Opposing regulatory roles of complement factor 5 in the development of bleomycin-induced pulmonary fibrosis. J. Immunol. 175: 1894-1902.
52. Hillebrandt, S., H. E. Wasmuth, R. Weiskirchen, C. Hellerbrand, H. Keppeler, A. Werth, R. Schirin-Sokhan, G. Wilkens, A. Geier, J. Lorenzen, et al. 2005. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat. Genet. 37: 835-843.
53. Iyer, A., T. M. Woodruff, M. C. Wu, C. Stylianou, R. C. Reid, D. P. Fairlie, S. M. Taylor, and L. Brown. 2011. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats. J. Cardiovasc. Pharmacol. 58: 479-486.
54. Kim, D. H., D. Sandoval, J. A. Reed, E. K. Matter, E. G. Tolod, S. C. Woods, and R. J. Seeley. 2008. The role of GM-CSF in adipose tissue inflammation. Am. J. Physiol. Endocrinol. Metab. 295: E1038-E1046.
55. Donath, M. Y., M. Böni-Schnetzler, H. Ellingsgaard, and J. A. Ehses. 2009. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. Physiology (Bethesda) 24: 325-331.
56. Donath, M. Y., D. M. Schumann, M. Faulenbach, H. Ellingsgaard, A. Perren, and J. A. Ehses. 2008. Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 31(Suppl 2): S161-S164.
57. Hull, R. L., G. T. Westermark, P. Westermark, and S. E. Kahn. 2004. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J. Clin. Endocrinol. Metab. 89: 3629-3643.
58. Klegeris, A., and P. L. McGeer. 2007. Complement activation by islet amyloid polypeptide (IAPP) and alpha-synuclein 112. Biochem. Biophys. Res. Commun. 357: 1096-1099.
59. Lim, J., A. Iyer, J. Y. Suen, V. Seow, R. C. Reid, L. Brown, and D. P. Fairlie. 2013. C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J. 27: 822-831.
60. Roy, C., A. Gupta, A. Fisette, M. Lapointe, P. Poursharifi, D. Richard, H. Lu, B. Lu, N. Gerard, C. Gerard, and K. Cianflone. 2013. C5a receptor deficiency alters energy utilization and fat storage. PLoS One 8: e62531.